We are excited to share our 2025 Annual Report. We are grateful to our partners, donors, and funders for their collaboration and continued support to WIRhE and our goal of eradicating Rh disease worldwide.
2025 Global Overview
Total number of individuals reached in-person in 2025: 2,804 individuals
These numbers reflect only direct, in-person participants, not including the many who have been reached digitally or via social media engagement.
Countries with Direct Outreach in 2025
Kenya: 100 people reached through a blood drive with the Coalition of Blood for Africa (CoBA) and the Coalition for Women’s Health in Africa (COWHA), supporting postpartum hemorrhage prevention and reinforcing the importance of safe, timely blood access for mothers.
Cameroon: 422 people reached during a Rh disease awareness campaign with the For Mom and Baby Foundation (FOMAB), significantly increasing knowledge among women – especially pregnant women – on Rh incompatibility and encouraging early testing and partner engagement.
Liberia: 153 people reached through women’s health and wellbeing workshops with the Mineke Foundation and the Help a Mother and Newborn Initiative (HMNI), strengthening understanding of safe pregnancy, genetics, and reproductive health through community-led learning.
Ghana: 200 people reached through a community medical outreach with Equal Help Ghana, delivering essential health services alongside blood group and Rh education, while strengthening local capacity for improved diagnostic practices.
Nigeria: 220 women and girls reached through blood group and Rh awareness outreach with the Rhesus Solution Initiative (RSI), closing critical knowledge gaps and promoting early antenatal care to prevent Rh-related pregnancy complications.
Sierra Leone: 839 people reached through a maternal and child health education pilot with Uman n pikin welbodi (UMPIWE), raising awareness on antenatal care, preventable diseases, and Rh disease while documenting barriers to care in rural communities.
Malawi: 870 women screened through the neonatal jaundice study with AFRICARhE and Queen Elizabeth Central Hospital, generating essential data to improve early detection, treatment, and prevention of severe newborn complications.
Our full report can be downloaded here